Effects of chronic treatment with the new ultra-long-acting β2-adrenoceptor agonist indacaterol alone or in combination with the β1-adrenoceptor blocker metoprolol on cardiac remodelling-Reference-Cited by-同舟云学术

Effects of chronic treatment with the new ultra-long-acting β2-adrenoceptor agonist indacaterol alone or in combination with the β1-adrenoceptor blocker metoprolol on cardiac remodelling

Published:2015-05-12 Issue:14 Volume:172 Page:3627-3637
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Rinaldi Barbara¹²,Donniacuo Maria¹,Sodano Loredana¹,Gritti Giulia¹,Martuscelli Eugenio³,Orlandi Augusto⁴,Rafaniello Concetta¹²,Rossi Francesco¹²,Calzetta Luigino³,Capuano Annalisa¹²,Matera Maria Gabriella¹

Affiliation:

1. Centre of Excellence for Cardiovascular Diseases; Second University of Naples; Naples Italy

2. Regional Centre for Pharmacovigilance and Pharmacoepidemiology; Department of Experimental Medicine; Section of Pharmacology L. Donatelli; Second University of Naples; Naples Italy

3. Department of Systems Medicine; University of Rome ‘Tor Vergata’; Rome Italy

4. Anatomic Pathology, Department of Biomedicine and Prevention; University of Rome ‘Tor Vergata’; Rome Italy

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.13148/fullpdf

Reference59 articles.

1. Role of the excessive amounts of circulating catecholamines and glucocorticoids in stress-induced heart disease;Adameova;Can J Physiol Pharmacol,2009

2. Myocardial G protein receptor-coupled kinase expression correlates with functional parameters and clinical severity in advanced heart failure;Aguero;J Card Fail,2012

3. Beneficial effects of chronic pharmacological manipulation of beta-adrenoreceptor subtype signaling in rodent dilated ischemic cardiomyopathy;Ahmet;Circulation,2004